Literature DB >> 6247017

Calcium reverses the inhibitory action of morphine on neuroeffector transmission in the mouse vas deferens.

P Illes, W Zieglgänsberger, A Herz.   

Abstract

In the mouse vas deferens, the amplitude of excitatory junction potentials (e.j.p.s.) recorded intracellularly from smooth muscle cells was found to be proportional to stimulus intensity. Normorphine (0.4-2-10 microM) reduced the amplitude of these postsynaptic transients and shifted the stimulus-response curve to the right; i.e. in its presence, higher stimulus intensities were required to elicit an e.j.p. of a similar size to one generated in its absence. Naloxone (0.4 microM) reversed the inhibitory effect of normophine (2 microM). Membrane potentials were unaffected by the concentrations of normorphine employed in solutions of varying ionic compositions. Manoeuvres designed to increase intracellular free calcium, that is increasing the extracellular Ca+ ion concentration (from 2.5 to 5 or 10 mM), removing Mg2+ ions from a medium containing 5 mM Ca2+ or applying 4-aminopyridine (100 microM), enhanced the e.j.p. amplitude and reversed the inhibitory effect of normorphine. Lowering the concentration of Ca2+ ions (from 2.5 to 1 mM) or increasing the concentration of Mg2+ ions (from 1.2 to 4.8 mM) in the bathing solution reduced the amplitude of e.j.p.s. Short trains of impulses (3Hz) facilitated the amplitude of successive e.j.p.s., probably by elevating the intracellular Ca2+ ion concentration. The inhibitory effect of normorphine upon these transients was inversely proportional to the length of the train. It is concluded that the reversal of the effect of normorphine by calcium does not occur at the level of the opiate receptor, and that the opiate depresses the stimulated release of the excitatory transmitter by a reduction in the supply of Ca2+ ions to the stimulus-release coupling mechanism in the sympathetic nerve terminals.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6247017     DOI: 10.1016/0006-8993(80)91299-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  19 in total

1.  Effect of chronic morphine treatment on alpha(2)-adrenoceptor mediated autoinhibition of transmitter release from sympathetic varicosities of the mouse vas deferens.

Authors:  S Karunanithi; N A Lavidis
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

2.  Effect of chronic morphine treatment on transmitter release from sympathetic varicosities of the mouse vas deferens.

Authors:  N A Lavidis
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

3.  The inhibitory effect of somatostatin peptides on the rat anococcygeus muscle in vitro.

Authors:  T Priestley; G N Woodruff
Journal:  Br J Pharmacol       Date:  1988-05       Impact factor: 8.739

4.  Effect of opiates on transmitter release from visualized hypogastric boutons innervating the rat pelvic ganglia.

Authors:  D A Warren; N A Lavidis
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

5.  Interactions among the effects of normorphine, calcium and magnesium on transmitter release in the mouse vas deferens.

Authors:  J D Milner; R A North; L V Vitek
Journal:  Br J Pharmacol       Date:  1982-05       Impact factor: 8.739

6.  Differential effect of stimulation strength in mouse vas deferens on inhibition of neuroeffector transmission by receptor type selective opioids.

Authors:  D Ramme; P Illes
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-01       Impact factor: 3.000

7.  The effect of opiates on the terminal nerve impulse and quantal secretion from visualized amphibian nerve terminals.

Authors:  N A Lavidis
Journal:  Br J Pharmacol       Date:  1995-06       Impact factor: 8.739

8.  An electrophysiological study of presynaptic alpha-adrenoceptors in the vas deferens of the mouse.

Authors:  P Illes; K Starke
Journal:  Br J Pharmacol       Date:  1983-02       Impact factor: 8.739

9.  Effects of opiates on synaptosomal calmodulin and calcium uptake.

Authors:  W Hoss; M Formaniak
Journal:  Neurochem Res       Date:  1983-02       Impact factor: 3.996

10.  Enhancement of delta- but not mu-opiate agonist binding by calcium.

Authors:  A Pfeiffer; A Herz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-05       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.